Biostate AI Partners with ACP to Advance MS Research with AI and RNA Sequencing
Biostate AI, a leader in artificial intelligence for RNA sequencing, has announced a strategic partnership with the Accelerated Cure Project (ACP), a nonprofit focused on accelerating research and improving outcomes for individuals with multiple sclerosis (MS). This collaboration aims to develop next-generation AI models for predicting disease progression and treatment responses in MS by leveraging the rich transcriptomic data from ACP’s biorepository.




